Fact CheckerSign in

NCT06479174Recruiting

Cognitive Strategies for Optimizing Brain Health And Managing Transgenerational Vascular Risk Factors Post-Stroke

Cognitive Strategies for Optimizing Brain Health And Managing Transgenerational Vascular Risk Factors Post-Stroke (CHAMPS for Transgenerational Risk)

Source: ClinicalTrials.gov · Last updated 9 Oct 2026

Brief summary (registry, in English)

People living with the cognitive effects of stroke are at risk for recurrent stroke and further cognitive decline. Also problematic is that stroke risk clusters in families and biological family members of people who have ischemic stroke may also be at increased risk of stroke and/or cognitive decline. The primary goal of this study is to test the feasibility of a virtually delivered cognitive strategy training and health coaching program to reduce vascular risk and promote brain health in persons with stroke and their biological family members.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
40 (estimated)
First submitted
14 Jun 2024
Start date
12 Oct 2023
Primary completion date
30 Oct 2026
Lead sponsor
University of New Mexico
Diseases
Stroke
NCT number
NCT06479174

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 12 Oct 2023 to the primary completion date, 30 Oct 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • For all participants:
  • not English speaking, reading, and understanding, and
  • no access to video-conference software on a computer or smart device

Who the study is looking for

  • primary diagnosis of acute ischemic stroke,
  • impairment of cognitive function (score \>1 on Quick Executive Interview - telephone screener),
  • absence of severe aphasia (score of 0 or 1 on NIH Stroke Scale),
  • absence of pre-stroke dementia (client report),
  • absence of major anxiety and depressive disorder (PHQ-9, GAD-7),
  • absence of drug and alcohol misuse within 3 months of study (AUDIT, DAST),
  • greater than 40 years of age,
  • having a potential family member who meets targeted family member criteria,
  • eligible for MRI and Remote Supervised-transcranial direct current stimulation (RS-tDCS) if in CHAMPS-TR plus RS-tDCS (e.g., not pregnant; no intracranial metal implants; no skin lesions on target sites for stimulation; no severe cardiopulmonary, renal or hepatic diseases; no pacemakers; no underlying medical reason for not engaging in MRI or tDCS).
    • The targeted family member will be:
  • a minimum of 18 years of age,
  • biological kin of person with stroke,
  • absence of dementia (client report),
  • absence of major anxiety and depressive disorder (PHQ-9, GAD-7),
  • absence of drug and alcohol misuse within 3 months of study (AUDIT, DAST),
  • greater than 18 years of age, and
  • having a sibling or parent who had an ischemic stroke

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of New Mexico Health Sciences Center
Coordinator of this site? Confirm its status
AlbuquerqueUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.